Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Piper betle extract is a botanical extract derived from the leaves of the *Piper betle* plant, commonly known as betel. It contains a variety of bioactive compounds, including eugenol, hydroxychavicol, and various polyphenols. Preclinical research indicates that the extract possesses significant antihypercholesterolemic and antioxidant properties. In animal models of hypercholesterolemia, it has been shown to reduce serum levels of total cholesterol, triglycerides, and low-density lipoprotein (LDL) while increasing high-density lipoprotein (HDL) and enhancing the activity of hepatic antioxidant enzymes such as superoxide dismutase and catalase. Its lipid-lowering efficacy is largely attributed to its constituent eugenol, which exhibits potency comparable to the statin drug lovastatin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on piper betle extract.